(Q71378091)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan, an AT1-selective non-peptide angiotensin II receptor antagonist (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

1 reference

1 reference

M R Goldberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

M W Lo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

T E Bradstreet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

M A Ritter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

P Höglund

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

18 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

115-119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00192369

18 October 2019

exact match

0 references

cites work

Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members

1 reference

12 December 2020

The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slices

1 reference

12 December 2020

Clinical relevance of cimetidine drug interactions

1 reference

12 December 2020

Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine

1 reference

12 December 2020

Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm

1 reference

12 December 2020

Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report

1 reference

12 December 2020

Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

1 reference

12 December 2020

The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.

1 reference

12 December 2020

Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent

1 reference

12 December 2020

Effect of cimetidine or ranitidine administration on nifedipine pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers

1 reference

12 December 2020

Pharmacology of Nonpeptide Angiotensin II Receptor Antagonists

1 reference

12 December 2020

Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients

1 reference

12 December 2020

A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension

1 reference

12 December 2020

Estimation of variance for harmonic mean half-lives.

1 reference

12 December 2020

Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00192369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751032%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference